NICE and AHSN to collaborate on best evidence-based healthcare
pharmafile | August 5, 2021 | News story | |
NICE and the Academic Health Science Network (AHSN) are to collaborate on best evidence-based healthcare to improve the lives of patients.
The two-year agreement will draw on the strengths, skills, and resources of both organisations in order to support the healthcare system in adopting evidence-based healthcare and innovations.
NICE and the AHSN Network share the common purpose of identifying and accelerating the uptake of well-evidenced innovations into the healthcare system and to improve quality, safety, outcomes and experience, as well as the effective use of resources.
This shared purpose underpins the aim to improve healthcare in the UK, and globally, and to support the UK’s reputation as a leader in healthcare innovation.
Prof Gillian Leng, NICE Chief Executive, said: “By working together more closely we can increase the speed at which innovative new medicines and technologies recommended by NICE can be cascaded through the healthcare system.
“Our work with the AHSN Network will also ensure we are helping to produce the vital real-world evidence needed to guide the development of NICE recommendations.
“One of the key priorities of our new 5-year strategy is to increase the uptake and use of NICE recommendations across the healthcare system to maximise the impact of our work and ensure everyone has access to the latest innovations.
“We can best achieve this by working strategically with our key partners such as the AHSN Network, and we’re delighted to announce this new collaboration between our organisations.”
Prof Gary Ford, Chair of the AHSN Network, Chief Executive of Oxford AHSN and Non-Executive Director for NICE said: “This agreement builds on the successes of our past collaborative working and will help us further our work to ensure patients have access to the latest evidence-based technologies, advice and guidance.
“NICE and the Network share a common goal to accelerate the rate of adoption and spread of evidence-based practice and innovation within the NHS, and by working together we can use our combined expertise and experience to improve health at pace and scale.”
Lilly Subbotin
